Emerging evidence implicates brain-derived neurotrophic factor (BDNF) and serotonin (5-HT) in the pathophysiology of depression and in the actions of antidepressant agents (Homberg et al., 2014; Mahar et al., 2014). Here, HTR5A is linked to depressive symptom measurement.